Tomorrow's Monsters
Un podcast de iHeartPodcasts
21 Épisodes
-
Alive Again | E1 | Crude Vessel, Perfect Peace
Publié: 13/05/2025 -
Alive Again - Coming May 13th
Publié: 06/05/2025 -
Introducing: Dream Sequence
Publié: 05/08/2024 -
Introducing: The Passage
Publié: 07/02/2024 -
Introducing: The Mantawauk Caves
Publié: 22/03/2023 -
Introducing: 12 Ghosts from Grim & Mild
Publié: 16/12/2022 -
Introducing: 13 Days of Halloween Season 3, Devil's Night
Publié: 19/10/2022 -
Introducing: Ephemeral Season 2
Publié: 14/05/2021 -
Epilogue
Publié: 07/04/2021 -
Season One Finale Part II - Humankind 2.0
Publié: 06/04/2021 -
Season One Finale Part I - A Little Trick My Father Taught Me
Publié: 06/04/2021 -
9. Hivemind
Publié: 30/03/2021 -
8. Kill Switch
Publié: 23/03/2021 -
7. The Beginning Of Our Future Selves
Publié: 16/03/2021 -
6. To Kill A Monster
Publié: 09/03/2021 -
5. Suspended in the Void
Publié: 02/03/2021 -
4. The Replay
Publié: 23/02/2021 -
3. The Shift
Publié: 16/02/2021 -
2. It's Not The Fall That Kills You
Publié: 09/02/2021 -
1. A Blueprint For Madness
Publié: 09/02/2021
Headphones are highly recommended for this immersive, psychological, sci-fi thriller! John Boyega (STAR WARS: THE FORCE AWAKENS) stars as Jack Locke, a mysterious conman with a vendetta who infiltrates NextCorp, a Silicon Valley body-hacking startup run by enigmatic CEO Max Fuller, played by Emmy winner Darren Criss (AMERICAN CRIME STORY: THE ASSASSINATION OF GIANNI VERSACE). Nextcorp has secretly been developing a revolutionary new mind app that promises to amplify the human brain in incredible ways. "Shut-Eye," promises to change the world by eliminating its users’ need to sleep, but when participants of the human trials begin dying off, the program is shut down. Max starts testing the product on himself, unleashing a dormant and dangerous alter ego. As Jack goes toe to toe with Max and his fractured psyche, he finds himself on the run for his life in a race to stop a dark plot seeking to radically advance humankind to its next stage of evolution.